Business

Life Sciences Virtual Investor Forum Agenda Announced for March 9th

Life Sciences Virtual Investor Forum Agenda Announced for March 9th.

articleValeo Pharma Inc.March 7, 20233/company/valeo-pharma-inc/news/life-sciences-virtual-investor-forum-agenda-announced-for-march-9th
Life Sciences Virtual Investor Forum Agenda Announced for March 9th

About this update from Valeo Pharma Inc.

[{"type":"text","content":"\n NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum to be held March 9th. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://tinyurl.com/0323LSIFVIC It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings with management. “We’re pleased to feature today’s innovators from the life sciences sector,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “Our Virtual Investor Conferences continue to provide a unique opportunity for these visionary companies to share their business strategies and engage a broader investor base.” March 9th EasternTime (ET)PresentationTicker(s)9:30 AMVolitionRX Ltd.NYSE American: VNRX10:00 AM Synlogic, Inc.Nasdaq: SYBX10:30 AMLisata Therapeutics, Inc.NASDAQ: LSTA11:00 AMInMed Pharmaceuticals Inc.NASDAQ: INM11:30 AMValeo Pharma Inc.OTCQB: VPHIF | TSX: VPH12:00 PM Roquefort Therapeutics plcOTCQB: ROQAF | LSE: ROQ To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com. About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Media Contact: OTC Markets Group Inc. +1 (212) 896-4428, [email protected] Virtual Investor Conferences Contact:Joh...

More updates from Valeo Pharma Inc.